These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14462655)

  • 1. Influence of pH, ionic strength, neutral ions, and thrombin on fibrin polymerization.
    LATALLO ZS; FLETCHER AP; ALKJAERSIG N; SHERRY S
    Am J Physiol; 1962 Apr; 202():675-80. PubMed ID: 14462655
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of polymerization of ancrod and thrombin fibrin monomers.
    Spellman GG; Macoviak JA; Gralnick HR
    Blood; 1977 Oct; 50(4):619-24. PubMed ID: 20184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic study on the initial stage of the fibrinogen-fibrin conversion by thrombin. (1) Application of mathematical treatment to turbidimetrical method.
    Sato H; Nakajima A
    Thromb Res; 1984 Mar; 33(6):645-51. PubMed ID: 6719406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The conversion of fibrinogen to fibrin. XII. Influence of pH, ionic strength and hexamethylene glycol concentration on the polymerization of fibrinogen.
    SHULMAN S; FERRY JD; TINOCO I
    Arch Biochem Biophys; 1953 Feb; 42(2):245-56. PubMed ID: 13031627
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of ioxaglate--an ionic low osmolar contrast medium--on fibrin polymerization in vitro.
    Brass O; Belleville J; Sabattier V; Corot C
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):689-97. PubMed ID: 8292718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The conversion of fibrinogen to fibrin. V. Influence of ionic strength and thrombin concentration on the effectiveness of certain reversible inhibitors.
    SHULMAN S; HERWIG WC; FERRY JD
    Arch Biochem Biophys; 1951 Jul; 32(2):354-8. PubMed ID: 14857755
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
    Mosesson MW; Hernandez I; Siebenlist KR
    Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cl- regulates the structure of the fibrin clot.
    Di Stasio E; Nagaswami C; Weisel JW; Di Cera E
    Biophys J; 1998 Oct; 75(4):1973-9. PubMed ID: 9746538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of temperature, pH and ionic strength and composition on fibrin network structure and its development.
    Nair CH; Shah GA; Dhall DP
    Thromb Res; 1986 Jun; 42(6):809-16. PubMed ID: 3726801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin clotting time and fibrin polymerization in liver cirrhosis.
    Szczepański M; Habior A; Szczepanik A; Soszka A; Grel K
    Mater Med Pol; 1994; 26(3):87-90. PubMed ID: 7603083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of ionic strength, pH and aptamer configuration for binding affinity to thrombin.
    Hianik T; Ostatná V; Sonlajtnerova M; Grman I
    Bioelectrochemistry; 2007 Jan; 70(1):127-33. PubMed ID: 16725379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanism for fibrin monomer aggregation based on a kinetic study.
    Usero JL; Burguillo FJ; Izquierdo C; Del Arco A; Herraez MA
    Int J Biochem; 1984; 16(5):553-9. PubMed ID: 6724108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of an effective fibrin beta-chain polymerization site: implications for the polymerization mechanism.
    Hsieh Kh
    Biochemistry; 1997 Aug; 36(31):9381-7. PubMed ID: 9235981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
    Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Equilibrium system consisting of soluble forms of fibrin and the specific anticoagulant D fragment of the firbinogen molecule].
    Smekhova KO; Ugarova TP; Pozdniakova TM; Belitser VO
    Ukr Biokhim Zh; 1977; 49(6):5-11. PubMed ID: 22149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for thrombin enhancement of fibrin polymerization that is independent of its catalytic activity.
    Kaminski M; Siebenlist KR; Mosesson MW
    J Lab Clin Med; 1991 Mar; 117(3):218-25. PubMed ID: 2002278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an acidic environment on coagulation dynamics.
    Gissel M; Brummel-Ziedins KE; Butenas S; Pusateri AE; Mann KG; Orfeo T
    J Thromb Haemost; 2016 Oct; 14(10):2001-2010. PubMed ID: 27431334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coarse-grained molecular dynamics simulations of fibrin polymerization: effects of thrombin concentration on fibrin clot structure.
    Yesudasan S; Wang X; Averett RD
    J Mol Model; 2018 Apr; 24(5):109. PubMed ID: 29623504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of fibrin oligomer formation observed by electron microscopy.
    Janmey PA; Erdile L; Bale MD; Ferry JD
    Biochemistry; 1983 Aug; 22(18):4336-40. PubMed ID: 6626504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.